CAS: 2241039-81-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | JAK1-IN-7 REF: 3D-RPD03981CAS: 2241039-81-4 | Min. 95% | A consultar | Mar 18 Feb 25 |
 | Londamocitinib REF: TM-T11706CAS: 2241039-81-4 | 99.47% | 176,00 €~1.531,00 € | Mar 08 Abr 25 |
JAK1-IN-7
CAS:2241039-81-4
JAK1-IN-7 is a peptide that binds to and inhibits JAK1. It has been used as …
Fórmula:
C28H31F2N7O4S
Pureza:
Min. 95%
Peso molecular:
599.7 g/mol
Ref: 3D-RPD03981
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
Londamocitinib
CAS:2241039-81-4
Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.
Fórmula:
C28H31F2N7O4S
Pureza:
99.47%
Forma y color:
Solid
Peso molecular:
599.65
Ref: TM-T11706
| 1mg | 176,00 € | ||
| 5mg | 430,00 € | ||
| 10mg | 584,00 € | ||
| 25mg | 884,00 € | ||
| 50mg | 1.141,00 € | ||
| 100mg | 1.531,00 € | ||
| 1mL*10mM (DMSO) | 554,00 € |
Entrega estimada en Estados Unidos, el Martes 8 de Abril de 2025
